67 related articles for article (PubMed ID: 1583404)
1. Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis.
Marder VJ; Brenner B; Totterman S; Francis CW; Rubin R; Rao AK; Kessler CM; Kwaan HC; Sharma GV; Fong KL
J Lab Clin Med; 1992 May; 119(5):485-95. PubMed ID: 1583404
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic therapy of deep vein thrombosis with continuous intravenous infusion of a recombinant tissue plasminogen activator.
Zimmerman R; Gürsoy A; Horn A; Harenberg J; Diehm C; Kübler W
Semin Thromb Hemost; 1991 Jan; 17(1):48-54. PubMed ID: 1904629
[TBL] [Abstract][Full Text] [Related]
3. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
Collen D; Stassen JM; De Cock F
Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction.
Seifried E; Tanswell P; Ellbrück D; Haerer W; Schmidt A
Thromb Haemost; 1989 Jun; 61(3):497-501. PubMed ID: 2508258
[TBL] [Abstract][Full Text] [Related]
7. Intermittent regional therapy with rt-PA is not superior to systemic thrombolysis in deep vein thrombosis (DVT)--a German multicenter trial.
Schwieder G; Grimm W; Siemens HJ; Flor B; Hilden A; Gmelin E; Friedrich HJ; Wagner T
Thromb Haemost; 1995 Nov; 74(5):1240-3. PubMed ID: 8607102
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial.
Bounameaux H; Banga JD; Bluhmki E; Coccheri S; Fiessinger JN; Haarmann W; Lockner D; Mahler F; Ninet J; Schneider PA
Thromb Haemost; 1992 Mar; 67(3):306-9. PubMed ID: 1641820
[TBL] [Abstract][Full Text] [Related]
10. Studies on the medical treatment of deep vein thrombosis.
Schulman S
Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
[TBL] [Abstract][Full Text] [Related]
11. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans.
Verstraete M; Bounameaux H; de Cock F; Van de Werf F; Collen D
J Pharmacol Exp Ther; 1985 Nov; 235(2):506-12. PubMed ID: 4057083
[TBL] [Abstract][Full Text] [Related]
13. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
[TBL] [Abstract][Full Text] [Related]
14. [Local thrombolysis in peripheral arterial occlusion].
Hess H
Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
[TBL] [Abstract][Full Text] [Related]
15. [Thrombolytic therapy of deep venous thrombosis with rt-PA].
Zimmermann R; Horn A; Harenberg J; Diehm C; Müller-Bühl U; Kübler W
Klin Wochenschr; 1988; 66 Suppl 12():137-42. PubMed ID: 3126342
[TBL] [Abstract][Full Text] [Related]
16. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of staphylokinase and alteplase in rabbit bleeding time models.
Vanderschueren S; Collen D
Thromb Haemost; 1996 May; 75(5):816-9. PubMed ID: 8725729
[TBL] [Abstract][Full Text] [Related]
18. [Intraoperative thrombolysis with rt-PA in massive pulmonary embolism during venous thrombectomy].
Scheeren TW; Hopf HB; Peters J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Nov; 29(7):440-5. PubMed ID: 7819477
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic properties in a rabbit jugular vein thrombosis model of a tissue-type plasminogen activator mutant lacking the growth factor--and kringle one-domains.
Emeis JJ; Verheijen JH
Arzneimittelforschung; 1992 Mar; 42(3):358-62. PubMed ID: 1497699
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tissue plasminogen activator (rt-PA) as first-line therapy for declotting of haemodialysis access.
Andriani M; Drago G; Bernardi AM; Da Porto A; De Luca M; Riegler P; Biasia F; Pinzani A
Nephrol Dial Transplant; 1995; 10(9):1714-9. PubMed ID: 8559494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
